https://7-cl-o-nec1inhibitor.c....om/compensatory-well
Recombinant adeno-associated virus (rAAV) vectors have proven effective in introducing genetic material into neural and glial cells of the retina, however, achieving targeted delivery to vascular endothelial cells (VECs) remains a persistent obstacle. To circumvent this restriction, we created rAAV capsid mutant vectors demonstrating improved targeting of retinal VEC. Serotype vectors of rAAV2/2, rAAV2/2[QuadYF-TV], and rAAV2/9 (n=9 capsid mutants pe
Like
Comment
Share
